Contact Us
  Search
The Business Research Company Logo

Presbyopia Market Report 2026

Buy Now
Global Presbyopia Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Presbyopia Market Report 2026

Global Outlook – By Treatment (Eyeglasses, Contact Lenses, Refractive Surgery, Lens Implants, Other Treatments), By Symptoms (Eye Strain, Headaches, Fatigue, Blurred Vision, Other Symptoms), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035

Presbyopia Market Overview

• Presbyopia market size has reached to $10.66 billion in 2025 • Expected to grow to $13.88 billion in 2030 at a compound annual growth rate (CAGR) of 5.4% • Growth Driver: Rising Vision Impairment Prevalence Driving Growth In The Market • Market Trend: Innovative Eye Care Solutions Improve Life For Aging Individuals • North America was the largest region in 2025.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Presbyopia Market?

Presbyopia refers to an age-related condition where the eye's lens loses flexibility, making it difficult to focus on close objects. It typically begins around the age of 40 and gradually worsens over time. Common solutions include reading glasses, bifocals, progressive lenses, and surgical treatments. The main treatment types of presbyopia are eyeglasses, contact lenses, refractive surgery, lens implants, and others. Eyeglasses are optical devices with lenses mounted in a frame, designed to correct vision impairments such as nearsightedness, farsightedness, astigmatism, and presbyopia. There are various symptoms such as eye strain, headaches, fatigue, blurred vision, and others, and they are used by several end-users such as hospitals, specialty clinics, home care, and others.
Presbyopia Market Global Report 2026 Market Report bar graph

What Is The Presbyopia Market Size and Share 2026?

The presbyopia market size has grown strongly in recent years. It will grow from $10.66 billion in 2025 to $11.26 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to aging global population, increasing prevalence of age-related vision disorders, widespread availability of corrective eyewear, expansion of ophthalmology clinics, improvements in vision correction technologies.

What Is The Presbyopia Market Growth Forecast?

The presbyopia market size is expected to see strong growth in the next few years. It will grow to $13.88 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing adoption of premium vision correction solutions, rising demand for surgical presbyopia treatments, expansion of outpatient eye care services, growing investments in ophthalmic R&D, increasing awareness of vision health management. Major trends in the forecast period include increasing adoption of advanced lens implant technologies, rising demand for progressive and multifocal solutions, growing use of minimally invasive surgical treatments, expansion of personalized vision correction options, enhanced focus on visual comfort and quality.

Global Presbyopia Market Segmentation

1) By Treatment: Eyeglasses, Contact Lenses, Refractive Surgery, Lens Implants, Other Treatments 2) By Symptoms: Eye Strain, Headaches, Fatigue, Blurred Vision, Other Symptoms 3) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users Subsegments: 1) By Eyeglasses: Bifocal Eyeglasses, Progressive Lenses, Reading Glasses, Photochromic Lenses 2) By Contact Lenses: Bifocal Contact Lenses, Multifocal Contact Lenses, Monovision Contact Lenses, Scleral Lenses 3) By Refractive Surgery: LASIK (Laser-Assisted In Situ Keratomileusis), PRK (Photorefractive Keratectomy), Conductive Keratoplasty (CK), Corneal Inlays 4) By Lens Implants: Multifocal Intraocular Lenses (IOLs), Accommodative IOLs, Extended Depth of Focus (EDOF) IOLs 5) By Other Treatments: Pharmaceutical Treatments, Corneal Cross-Linking, Near-vision Presbyopia Correction Surgery

What Is The Driver Of The Presbyopia Market?

The increasing prevalence of vision impairment is expected to propel the growth of the presbyopia market going forward. Vision impairment is a condition where a person experiences partial or complete loss of eyesight that cannot be fully corrected with glasses, contact lenses, or medical treatment. The growing prevalence of vision impairment is driven by an aging population, increasing diabetes and eye diseases, excessive screen time, and inadequate access to eye care in certain areas. Presbyopia contributes to vision impairment by reducing the eye’s ability to focus on near objects due to age-related lens stiffening, making everyday tasks like reading and screen use more challenging without corrective measures. For instance, in February 2025, according to the American Foundation for the Blind (AFB), a US-based non-profit organization, in the United States, there were about 625,000 children with vision problems, according to the 2023 American Community Survey (ACS). Therefore, the increasing prevalence of vision impairment is driving the growth of the presbyopia industry.

Key Players In The Global Presbyopia Market

Major companies operating in the presbyopia market are Johnson & Johnson Private Limited, AbbVie Inc., Abbott Laboratories, Novartis AG, Essilor International SAS, Carl Zeiss Meditec AG, Alcon Vision LLC, Bausch + Lomb Corporation, CooperVision Inc., Santen Pharmaceutical Co. Ltd., Glaukos Corporation, STAAR Surgical Company, Ziemer Ophthalmic Systems AG, LENZ Therapeutics Inc., InSight Vision Incorporated, Oculis Holding AG, Orasis Pharmaceuticals Inc., Visus Therapeutics Inc., Eyenovia Inc., Atia Vision Inc.

What Are Latest Mergers And Acquisitions In The Presbyopia Market?

In January 2023, Bausch + Lomb, a Canada-based eye health company specializing in ophthalmic pharmaceuticals, acquired AcuFocus for an undisclosed amount. With this acquisition, Bausch + Lomb aims to expand its vision care portfolio by integrating AcuFocus' innovative small-aperture technologies, including the IC-8 Apthera intraocular lens (IOL) for presbyopia and cataract patients. AcuFocus is a US-based company that specializes in developing ophthalmic medical devices for the treatment of presbyopia and other vision disorders.

Regional Outlook

North America was the largest region in the presbyopia market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Presbyopia Market?

The presbyopia market consists of revenues earned by entities by providing services such as corneal inlay procedures, refractive surgery services, and vision therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The presbyopia market includes sales of bifocal lense, multifocal contacts, refractive lens exchange (RLE), and prescription eye drops. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Presbyopia Market Report 2026?

The presbyopia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the presbyopia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Presbyopia Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$11.26 billion
Revenue Forecast In 2035$13.88 billion
Growth RateCAGR of 5.6% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredTreatment, Symptoms, End-Users
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledJohnson & Johnson Private Limited, AbbVie Inc., Abbott Laboratories, Novartis AG, Essilor International SAS, Carl Zeiss Meditec AG, Alcon Vision LLC, Bausch + Lomb Corporation, CooperVision Inc., Santen Pharmaceutical Co. Ltd., Glaukos Corporation, STAAR Surgical Company, Ziemer Ophthalmic Systems AG, LENZ Therapeutics Inc., InSight Vision Incorporated, Oculis Holding AG, Orasis Pharmaceuticals Inc., Visus Therapeutics Inc., Eyenovia Inc., Atia Vision Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Frequently Asked Questions

The Presbyopia market was valued at $10.66 billion in 2025, increased to $11.26 billion in 2026, and is projected to reach $13.88 billion by 2030.
request a sample here
The global Presbyopia market is expected to grow at a CAGR of 5.4% from 2026 to 2035 to reach $13.88 billion by 2035.
request a sample here
Some Key Players in the Presbyopia market Include, Johnson & Johnson Private Limited, AbbVie Inc., Abbott Laboratories, Novartis AG, Essilor International SAS, Carl Zeiss Meditec AG, Alcon Vision LLC, Bausch + Lomb Corporation, CooperVision Inc., Santen Pharmaceutical Co. Ltd., Glaukos Corporation, STAAR Surgical Company, Ziemer Ophthalmic Systems AG, LENZ Therapeutics Inc., InSight Vision Incorporated, Oculis Holding AG, Orasis Pharmaceuticals Inc., Visus Therapeutics Inc., Eyenovia Inc., Atia Vision Inc. .
request a sample here
Major trend in this market includes: Innovative Eye Care Solutions Improve Life For Aging Individuals. For further insights on this market.
request a sample here
North America was the largest region in the presbyopia market in 2025. The regions covered in the presbyopia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here
Research Expert

Book your 30 minutes free consultation with our research experts

Chat with us